Dynamic AVF Valve
Vascular access for hemodialysis in End-Stage Kidney Disease (ESKD)
Pre-clinicalActive
Key Facts
Indication
Vascular access for hemodialysis in End-Stage Kidney Disease (ESKD)
Phase
Pre-clinical
Status
Active
Company
About XS Innovations
XS Innovations is targeting a critical unmet need in renal care: the high rate of complications associated with vascular access for hemodialysis. The company's breakthrough solution is the Dynamic AVF, an implantable valve that regulates blood flow through the AVF, activating only during treatment to minimize continuous hemodynamic stress. This approach aims to reduce complications like steal syndrome, aneurysms, and cardiac overload while improving access patency. With the global ESKD patient population growing rapidly, XS Innovations' technology has the potential to significantly improve standard of care and reduce healthcare costs associated with access failure.
View full company profile